Astha Pharma Private Limited

Produces pharmaceutical products for private distribution.

2012 | Mumbai, Maharashtra (India) | Inactive
Last Updated: February 15, 2025

Astha Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 2 Months
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth %
  • Profit Growth 97.47%
  • Ebitda 97.50%
  • Net Worth -2.37%
  • Total Assets %

About Astha Pharma

Astha Pharma Private Limited (APPL) is Strike Off company established on 07 Dec 2012 with its office registered at Mumbai, Maharashtra, India and has been running since 12 Year, 2 Months with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 15 Feb 2025.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24233MH2012PTC238574

  • Company No.

    238574

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    07 Dec 2012

  • Date of AGM

    19 Sep 2017

  • Date of Balance Sheet

    31 Mar 2017

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Astha Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Shahid Khan Country flag representing In Additional Director 04-Feb-2016Current
Sainaj Bhanvadia Country flag representing In Director 04-Feb-2016Current

Financial Performance of Astha Pharma.

Astha Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.47% increase in profit. The company's net worth dipped by a decrease of 2.37%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
97.47%
Net Worth
-2.37%
EBITDA
97.50%

What is the Ownership and Shareholding Structure of Astha Pharma?

In 2017, Astha Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Astha Pharma?

Unlock and access historical data on people associated with Astha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Astha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astha Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Astha Pharma

Recent activity within the organization

  • Annual General Meeting

    Astha Pharma Private Limited last Annual general meeting of members was held on 19 Sep 2017 as per latest MCA records.

    19 Sep 2017

  • Balance Sheet

    Astha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai.

    31 Mar 2017

  • Director Appointment

    Shahid Mohammad Khan was appointed as a Additional Director was appointed as a Additional Director on 04 Feb 2016 & has been associated with this company since 9 years 20 days .

    04 Feb 2016

  • Director Appointment

    Sainaj Samsudin Bhanvadia was appointed as a Director was appointed as a Director on 04 Feb 2016 & has been associated with this company since 9 years 20 days .

    04 Feb 2016

  • Company Incorporation

    Astha Pharma Private Limited was registered on 07 Dec 2012 with Roc Mumbai & aged 12 years 2 months as per MCA records.

    07 Dec 2012

Frequently asked questions

  • Astha Pharma Private Limited was incorporated on 07 Dec 2012.

  • The authorized share capital of Astha Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Astha Pharma Private Limited.

    • Shahid Mohammad Khan
    • Sainaj Samsudin Bhanvadia
  • As per Ministry of Corporate Affairs (Mca), the registered address of Astha Pharma Private Limited is Flat No. 202 2Nd Floor A-Wing The Crossgate Chs Plot 334 Lokhandwala Complex Andhe Ri West, India, Mumbai, Maharashtra, 400053.

  • The corporate identification number (CIN) of Astha Pharma Private Limited is U24233MH2012PTC238574 and the company number is 238574 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2017 indicates that The net worth of Astha Pharma Private Limited has experienced an downturn of -2.37%.

  • The most recent Balance Sheet for Astha Pharma Private Limited was filed with the ROC on 31 Mar 2017.

People also Viewed

Similar Companies Based on Drug Formulation & Development